Suppr超能文献

对流增强递送

Convection-Enhanced Delivery.

作者信息

Mehta A M, Sonabend A M, Bruce J N

机构信息

Department of Neurological Surgery, Columbia University Medical Center, New York, NY, 10032, USA.

出版信息

Neurotherapeutics. 2017 Apr;14(2):358-371. doi: 10.1007/s13311-017-0520-4.

Abstract

Convection-enhanced delivery (CED) is a promising technique that generates a pressure gradient at the tip of an infusion catheter to deliver therapeutics directly through the interstitial spaces of the central nervous system. It addresses and offers solutions to many limitations of conventional techniques, allowing for delivery past the blood-brain barrier in a targeted and safe manner that can achieve therapeutic drug concentrations. CED is a broadly applicable technique that can be used to deliver a variety of therapeutic compounds for a diversity of diseases, including malignant gliomas, Parkinson's disease, and Alzheimer's disease. While a number of technological advances have been made since its development in the early 1990s, clinical trials with CED have been largely unsuccessful, and have illuminated a number of parameters that still need to be addressed for successful clinical application. This review addresses the physical principles behind CED, limitations in the technique, as well as means to overcome these limitations, clinical trials that have been performed, and future developments.

摘要

对流增强递送(CED)是一种很有前景的技术,它在输液导管尖端产生压力梯度,以直接通过中枢神经系统的间隙递送治疗药物。它解决了传统技术的许多局限性并提供了解决方案,能够以靶向且安全的方式递送药物越过血脑屏障,从而达到治疗药物浓度。CED是一种广泛适用的技术,可用于递送多种治疗化合物来治疗多种疾病,包括恶性胶质瘤、帕金森病和阿尔茨海默病。自20世纪90年代初开发以来,虽然已经取得了一些技术进步,但CED的临床试验在很大程度上并不成功,并且揭示了一些成功应用于临床仍需解决的参数。本综述阐述了CED背后的物理原理、该技术的局限性、克服这些局限性的方法、已进行的临床试验以及未来的发展。

相似文献

1
Convection-Enhanced Delivery.
Neurotherapeutics. 2017 Apr;14(2):358-371. doi: 10.1007/s13311-017-0520-4.
2
Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations.
Brain Pathol. 2014 Mar;24(2):117-27. doi: 10.1111/bpa.12082. Epub 2013 Sep 11.
3
Convection-Enhanced Delivery for Management of Malignant Gliomas.
Prog Neurol Surg. 2018;32:152-158. doi: 10.1159/000469687. Epub 2018 Jul 10.
4
Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Neurol Med Chir (Tokyo). 2017 Jan 15;57(1):8-16. doi: 10.2176/nmc.ra.2016-0071. Epub 2016 Dec 15.
5
Future of convection-enhanced delivery in the treatment of brain tumors.
Future Oncol. 2010 Jan;6(1):117-25. doi: 10.2217/fon.09.135.
6
Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Curr Drug Deliv. 2007 Apr;4(2):169-80. doi: 10.2174/156720107780362302.
7
Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas.
Neurosurg Focus. 2006 Apr 15;20(4):E13. doi: 10.3171/foc.2006.20.4.8.
8
Convection-enhanced delivery in clinical trials.
Neurosurg Focus. 2003 Feb 15;14(2):e2. doi: 10.3171/foc.2003.14.2.3.
9
Convection-enhanced delivery of targeted toxins for malignant glioma.
Expert Opin Drug Deliv. 2006 May;3(3):371-7. doi: 10.1517/17425247.3.3.371.
10
Neurosurgical convection-enhanced delivery of treatments for Parkinson's disease.
J Clin Neurosci. 2011 Sep;18(9):1163-7. doi: 10.1016/j.jocn.2011.01.012. Epub 2011 Jul 13.

引用本文的文献

4
Harnessing immunotherapy: cancer vaccines as novel therapeutic strategies for brain tumor.
Front Immunol. 2025 Jul 17;16:1588081. doi: 10.3389/fimmu.2025.1588081. eCollection 2025.
5
[Dynamic distribution and clearance of Tc-DTPA in brain extracellular space].
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):562-568. doi: 10.19723/j.issn.1671-167X.2025.03.021.
6
Lu-Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer.
Small Sci. 2024 Dec 12;5(5):2400550. doi: 10.1002/smsc.202400550. eCollection 2025 May.
7
8
Advances in the Repurposing and Blood-Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors.
Cancers (Basel). 2025 Jan 27;17(3):439. doi: 10.3390/cancers17030439.
9
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.
Mater Today Bio. 2025 Jan 4;31:101457. doi: 10.1016/j.mtbio.2025.101457. eCollection 2025 Apr.
10
Therapeutic manipulation and bypass of the blood-brain barrier: powerful tools in glioma treatment.
Neurooncol Adv. 2025 Jan 15;7(1):vdae201. doi: 10.1093/noajnl/vdae201. eCollection 2025 Jan-Dec.

本文引用的文献

1
Delivering therapy to target: improving the odds for successful drug development.
Ther Deliv. 2016 Jul;7(7):457-81. doi: 10.4155/tde-2016-0016.
2
Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.
Curr Neuropharmacol. 2017;15(1):116-128. doi: 10.2174/1570159x14666160614093615.
3
Oncolytic viruses: a new class of immunotherapy drugs.
Nat Rev Drug Discov. 2015 Sep;14(9):642-62. doi: 10.1038/nrd4663.
4
Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.
CNS Oncol. 2015;4(4):225-34. doi: 10.2217/cns.15.12. Epub 2015 Jun 24.
7
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26.
8
Convection-enhanced drug delivery for gliomas.
Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S59-67. doi: 10.4103/2152-7806.151337. eCollection 2015.
9
Convection-enhanced delivery to the central nervous system.
J Neurosurg. 2015 Mar;122(3):697-706. doi: 10.3171/2014.10.JNS14229. Epub 2014 Nov 14.
10
Image-guided convection-enhanced delivery into agarose gel models of the brain.
J Vis Exp. 2014 May 14(87):51466. doi: 10.3791/51466.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验